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Wednesday, February 6, 2013 623aeffect of these substances. The therapeutic consequences in cases of poisoning
by organophosphorus compounds has yet to be tested.
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Nicotinic acetylcholine receptors (nAChRs) belong to the superfamily of
ligand-gated ion channels. The most abundant homomeric nAChR in the mam-
malian brain are the pentameric a7 nAChRs, which consist of five a7 subunits.
Positive allosteric modulators (PAMs) of nAChRs have been implicated to be
putative therapeutics in the pharmacological treatment of Alzheimer’s disease,
schizophrenia and Parkinson’s disease.
Recently, Sitzia et al. (2011) showed a striking temperature dependence for
positive allosteric modulation of PNU-120596 on nAChRs. The aim of our
study was to investigate the temperature dependence of other PAMs on
nACHRs with automated patch clamp techniques. For this study, we have
used GH4C1cells expressing human nAChR a7 subunits. Electrophysiological
recordings were performed on the Patchliner, a robotic patch clamp device
allowing temperature controlled recordings
from up to 8 cells simultaneously.
First experiments on GABAA receptors al-
lude to a similar but weaker effect on the
temperature dependence of PAMs.
These data suggest that experiments on the
efficacy of PAMs conducted at room tem-
perature have to be interpretedwith caution.
Sitzia et al (2011) FrontPharmacol;2:81.3203-Pos Board B358
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Background: Recent studies have indicated that various components of cardiac
nerve network may play important role in atrial fibrillation (AF). Vagal stimu-
lation shortens atrial effective refractory period, predominantly via the activa-
tion of the acetylcholine-activated potassium channel (IKACh) that shortens
action potential duration and increases the vulnerability to AF. Vasoactive in-
testine polypeptide (VIP), a neural polypeptide co-released with acetylcholine
(ACh) largely from intrinsic cardiac neurons during vagal stimulation, was
shown to contribute to the vulnerability to AF. However, the underlying mech-
anism remains unclear. The aim of this study is to investigate the effect of VIP
on IKACh in the presence of ACh in rat atrial myocytes.
Methods: The effects of VIP on IKACh in isolated adult rat atrial myocytes
were investigated with voltage patch-clamp recording techniques. IKACh
were recorded as an inwardly rectifying current activated by muscarinic agonist
carbachol (CCH, 1mM). Furthermore, the post-synaptic signal pathway was in-
vestigated with Rp-cAMP (10 mM), a competitive antagonist of cyclic AMP
(cAMP), H-89 (0.1mM), PKA inhibitor, and forskolin (0.1mM), an activator
of adenylyl cyclase.
Results: VIP (1mM) potentiates IKACh at a holding potential of 115 mV
(VIP: 19.34 5 5.22 pA/pF, n=12, vs. baseline: 15.85 5 2.66 pA/pF,
n=14, p<0.05). The enhancement of IKACh by VIP could be mitigated by
Rp-cAMP (VIP plus Rp-cAMP: 8.245 1.44 pA/pF n= 6; p<0.05 vs. base-
line), and could be inhibited by H-89 (VIP plus H-89: 13.41 5 2.95 pA/pF
n=6; p=0.59 vs. baseline). Furthermore, these enhancements could be mim-
icked by an activator of adenylyl cyclase, forskolin (27.35 5 4.82pA/pF
n= 5; p<0.01 vs. baseline).
Conclusion: VIP enhanced IKACh in atrial myocytes which might contribute to
vagal-induced APD shortening and is likely mediated by a cAMP-PKA depen-
dent pathway.
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Stockholm, Sweden.Pentameric Ligand Gated Ion Channels (pLGICs) are membrane receptors
widely spread in the animal kingdom that play a key role in the nervous signal
transduction. The discovery and the crystallization of bacterial homologues,
such as GLIC from Gloeobacter violaceus in 2008 (Bocquet et al., Nature,
2008, 457:111; Hilf & Dutzler, Nature, 2008, 457:115) and of a novel
locally-closed form (Nury et al. Nature, 2011, 469:428) provided new insights
in the understanding of the operating mechanism of these channels.
General anesthetics (GAs) such as propofol and desflurane could be co-
crystallized with GLIC (see for example Nury et al., Nature, 2011, 469:428).
The potential existence of several binding sites for GAs, alcohols and ions
that modulate the activity of the channel is currently debated.
Here, we intend to study the dynamic properties of the interactions between
GLIC-desflurane and GLIC-propofol by means of molecular dynamics simula-
tions, on the basis of existing crystal structures of open and locally-closed
forms of the channel. We computed more than one hundred all-atom simula-
tions of the ligand-bound GLIC system inserted in a membrane to obtain sig-
nificant statistics on the exploration of the cavity by desflurane and propofol.
We complete this study by free energy calculations to estimate the affinity of
propofol and desflurane to both the inter- and intra-subunit cavities. This ap-
proach may allow us to explore the ligand-filled cavity rather exhaustively
and provide a sound background for deriving hypotheses on GAs.
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Drug discovery on ion channel targets has been an under-explored territory
because suitable screening tools for patch clamp were missing. This changed
during the 2000’s with the introduction of automated patch clamp (APC)
devices. Still, the throughput and running cost of APC devices did not allow
for the employment of the patch clamp assays in primary screening. Because
of this bottleneck, APC has remained a secondary screening tool. We are
now presenting data from the first true gigaseal-based 384-channel planar patch
clamp system, the Qube, capable of providing the throughput needed for
primary screening. The Qube is a collection of years of experience with planar
patch clamp devices: High quality, reliability and easy to use concepts are the
core in both the tried-and-tested silicon technology of the consumable, and in
the technologies used in the instrument. The Qube offers GU seals and efficient
integrated liquid flow in 384-well format.
We show here that the Qube provides exceptional data quality for electrophys-
iological assays with fast desensitizing ligand-gated ion channels. The fast
liquid exchange permits accurate XC50 estimations. We have tested the acid
sensing ion channel (ASIC1) and the nicotinic acetylcholine receptor
(nAchRa1) on the Qube in both agonist and antagonist configurations, show-
casing the instrument’s broad flexibility in terms of assay design.
The results prove that: 1) Repetitive agonist applications result in reproducible
current responses. 2) The agonist can be applied and washed off an unlimited
number of times as long as the cell is stable. 3) XC50 values correspond to ex-
pected values (QPatch and literature).
Collectively, our results show that the design of the flow channels on the Qube
consumable enables recordings on ligand-gated ion channels with the highest
throughput capacity seen so far, without compromising data quality, reproduc-
ibility or reliability.
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Time-dependent changes in monovalent cation permeability have been re-
ported for P2XR, TRPV1 and TRPA1. An important physiological question
is whether relative Ca2þ permeability (PCa/PNa) also changes during prolonged
agonist exposure. Previous evidence obtained using current reversal potential
(ERev) measurements suggests this to be the case for TRPV1, but it is not known
for P2XRs. In our hands, both TRPV1- and P2X-transfected HEK293 cells
exhibited time-dependent changes in N-methyl-D-glucamine permeability
during prolonged exposure to capsaicin (10 microM) or ATP (30 microM)
respectively, which occurred immediately and was complete within 10-15 s.
Next we used patchclamp photometry to study time-dependent changes in frac-
tional Ca2þ current (Pf%). These experiments were problematic due to Ca2þ
entry often saturating the pipette Ca2þ chelator, fura-2, even under conditions
of low external Ca2þ. Nevertheless, in experiments where fura-2 saturation did
not occur within the first 5-10 seconds of stimulus, the relationship between to-
tal charge influx and change in fura-2 fluorescence was linear for both channels,
